Previous Article | Next Article ![]()
Molecular and Cellular Biology, September 2004, p. 7559-7566, Vol. 24, No. 17
0270-7306/04/$08.00+0 DOI: 10.1128/MCB.24.17.7559-7566.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Department of Pathology and Laboratory Medicine, Winship Cancer Institute,1 Graduate Program in Genetics and Molecular Biology, Emory University School of Medicine, Atlanta, Georgia2
Received 2 April 2004/ Returned for modification 3 May 2004/ Accepted 3 June 2004
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
The Snail superfamily is characterized by a common protein organization. Family members contain a highly conserved region at the carboxyl terminus of the protein containing four to six zinc fingers of the C2H2 type (16, 29). The zinc fingers mediate sequence-specific interactions with DNA. Snail superfamily members bind specifically to consensus binding sites that contain the core sequence CAGGTG (16, 29). This motif constitutes a subset of the E-box (CANNTG), the conserved binding site of basic helix-loop-helix transcription factors (29). The amino termini of the superfamily are less well conserved, although most vertebrate members contain the evolutionarily conserved SNAG (for Snail/Gfi) domain at their extreme amino termini (16, 29). In addition, a conserved sequence motif near the zinc fingers differentiates Slug genes from other members of the superfamily (16, 29).
Snail superfamily members function as transcriptional repressors (16, 29). Transcriptional repression function is associated with various conserved protein domains. In vertebrates, the SNAG domain is essential to transcriptional repression function of Snail family members. Drosophila Snail lacks the SNAG domain, yet it still functions as a transcriptional repressor, through interaction with a well-characterized corepressor, CtBP (16, 29). Consensus sequences for interaction with CtBP are found in some, but not all, members of the Snail superfamily (29).
The Snail gene is essential for normal development of both Drosophila melanogaster (21) and mice (7). Homozygous null embryos in both species fail to produce mesoderm, resulting in a failure to gastrulate (7). The failure of mesodermal specification in Snail mutant embryos led to the characterization of Snail as a master regulator of epithelial to mesenchymal transitions (21). Slug, in contrast, is not essential for normal development in the mouse. Homozygous null animals are viable and fertile (23). Despite the lack of an embryonic lethal phenotype in mice, Slug has been implicated in epithelial to mesenchymal transitions during development in other vertebrates. In embryogenesis in the chick and in Xenopus sp., Slug function is required for specification of neural crest (21, 29). Thus, Snail and Slug function to promote cell fate changes during development, leading to the production of migratory, mesenchymal cells.
In addition to their roles in pattern formation and specification of mesoderm, some members of the Snail superfamily have been implicated in cell survival. The Caenorhabditis elegans CES-1 (for cell death specification) protein is a member of the Snail superfamily (most closely related to Drosophila Scratch) that can block programmed cell death of the NSM sister neurons during embryogenesis (28). In vertebrates, Slug is aberrantly upregulated by the E2A-HLF oncoprotein in certain leukemias, leading to increased cell survival (20). Further analysis of Slug during hematopoiesis has revealed a nonpathological role for Slug in promoting cell survival in hematopoietic progenitor cells (19, 33).
We investigate here the phenotypic change induced in human breast carcinoma cells after ectopic expression of Snail or of Slug. Aberrant expression of these factors has been proposed as a key determinant of pathological epithelial to mesenchymal transitions during tumor progression (29). As expected, these transcription factors induced phenotypic alterations in epithelial breast cancer cells, including loss of cell-cell contacts and acquisition of invasive growth. Surprisingly, this phenotypic change was accompanied by a dramatic alteration in the apoptotic response to the common chemotherapeutic agent, adriamycin. Cells expressing Snail or Slug were protected from apoptosis induced by this DNA-damaging agent. Analysis of apoptotic pathways revealed that ectopic expression of Snail leads to downregulation of multiple genes with known roles in programmed cell death.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Amplified Snail fragments were subcloned to pcDNA3.1 (Invitrogen). Human Slug was cloned by PCR amplification from IMAGE clone no. 3908245 by using the following primers: Slug sense (5'-CGCGGATCCGCCGCCATGCCGCGCTCCTTCCTGGTC-3') and Slug antisense (5'-TCACTCGAGCTAAGCGTAATCGGGGACATCGTAGGGGTAGTGTGCTACACAGCAGCCAGATTCC-3').
Amplified fragments were subcloned into pcDNA3.1 (Invitrogen). Adenovirus for expression of Snail or Slug with a hemagglutinin (HA) epitope tag was prepared as described previously (15).
To construct Snail short hairpin RNA (shRNA-snail), sense and antisense DNA oligonucleotides were designed form double-stranded RNA with a loop structure: Snail shRNA sense (5'-GGATCCCGCGAGCTGCAGGACTCTAAGAAGCTTGTTAGAGTCCTGCAGCTCGCTTTTTT-3') and Snail shRNA antisense (5'-CTAGAAAAAAGCGAGCTGCAGGACTCTAACAAGCTTCTTAGAGTCCTGCAGCTCGCGG-3').
After annealing, the fragment was subcloned in to pGE-1 vector (Stratagene). shRNA-snail adenovirus was constructed by excising the shRNA-snail fragment, along with the U6 promoter from shRNA-snail/pGE-1, and ligating the fragment into pAdTrack, from which the cytomegalovirus promoter used for protein expression had been deleted. Adenoviruses were purified by CsCl banding.
Cell culture, transfection, and drug treatment. Cell lines from human breast carcinoma (MCF7) and melanoma (A375) were obtained from the American Type Culture Collection and cultured in Dulbecco modified Eagle medium supplemented with 10% fetal bovine serum and penicillin-streptomycin. MCF7 cells were treated with 3 µM adriamycin (ADR) for 2 h before culture in drug-free medium for the indicated times. Terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL) assays were performed by using commercially available reagents (In Situ Cell Death Detection Kit TMR red; Roche) according to the manufacturer's protocol after fixation as described previously (9).
Antibody and Western blotting. Human Snail antibodies were generated in rabbits by using His6-tagged recombinant Snail protein (amino acids 1Met to 146Lys). For affinity purification, recombinant Snail was coupled to N-hydroxysuccinimide-activated Sepharose 4 Fast flow (Amersham). Other antibodies utilized included: anti-E-cadherin monoclonal antibody (MAb; Zymed), antioccludin MAb (Zymed), anti-HA MAb (Roche), antiactin MAb (Chemicon), and anti-p53 MAb (Oncogene).
Immunofluorescence staining. Infected cells were seeded on glass coverslips, fixed with 2% paraformaldehyde in phosphate-buffered saline, and covered with blocking solution (10% fetal bovine serum-phosphate-buffered saline). Subsequently, cells were incubated with antioccludin MAb. After the cells were counterstained with goat anti-mouse antibody conjugated with Texas red, the slides were examined and photographed by using a Zeiss LSM510 laser scanning confocal microscope (Zeiss Microimaging, Inc.).
In vitro invasion analysis. Mock and Snail adenovirus-infected cells (2.5 x 105 cells) were seeded on Matrigel invasion chambers (BD Bioscience). After 22 h of incubation in a humidified incubator, noninvading cells were removed, and the invaded cells were fixed and stained with crystal violet. Stained cell were counted by using a microscope.
RT-PCR. Total RNA was extracted by a guanidinium thiocyanate-phenol-chloroform extraction method (11). cDNA was synthesized with Moloney murine leukemia virus reverse transcriptase by using random hexamers. To quantify mRNA, reverse transcription-PCR (RT-PCR) with real-time quantitation was performed by using the iCycler System (Bio-Rad) as described previously (11). Primer sequences are available on request.
ChIP analysis. Chromatin immunoprecipitation (ChIP) was performed by using a ChIP assay kit (Upstate) as described previously (11). In brief, cells were cross-linked with 1% formaldehyde and sonicated to generate 300- to 3,000-bp DNA fragments. Immunoprecipitation was performed with anti-HA MAb (Roche) and control antibody (Upstate). Precipitated DNAs were detected by PCR by using specific primers. Primer sequences are available on request.
| RESULTS |
|---|
|
|
|---|
|
|
Given the function of Snail and of Slug as transcriptional repressors, their ability to interfere with the apoptotic program is predicted to result from alterations in gene expression. Since the tumor suppressor p53 plays an integral role in cellular responses to DNA damage, the role of Snail and Slug in p53 regulation was investigated. Expression of either Snail or Slug resulted in modest downregulation of steady-state levels of p53 mRNA (Fig. 3a), in keeping with the observation that the TP53 locus contains numerous potential binding sites for Snail and Slug. In addition to p53, mRNA levels for additional proapoptotic factors whose genomic loci contain potential binding sites for Snail and Slug were analyzed. Steady state mRNA levels of the apoptotic nuclease DFF40 (26), as well as Mst4, a kinase implicated in the apoptotic response (8), declined significantly in response to expression of Snail or of Slug (Fig. 3a). Occludin and E-cadherin, included as positive controls, demonstrated the expected Snail- or Slug-dependent decreases in mRNA levels (Fig. 3a). Expression of Snail also resulted in a modest decline in the steady-state level of p53 at the protein level (Fig. 3b). Similar results were obtained after expression of Slug or coexpression of Snail and Slug (Fig. 3b).
|
Factors implicated in the stabilization of p53 showed a mixed response. ARF, the alternative reading frame product of the p16INK4a gene, stabilizes p53 independent of the DNA-damage response through inhibition of MDM2-dependent p53 turnover (36). ARF mRNA levels were unaffected by ADR treatment or by expression of either Snail or Slug (Fig. 3d). The checkpoint kinase CHK2 has been implicated in p53 stabilization through phosphorylation of the protein after DNA damage in mouse cells (17), although the relevance of this observation in human cells has recently been questioned (1, 22). CHK2 mRNA levels were not altered either by Snail expression, by Slug expression, or by ADR treatment (Fig. 3d). ATM, the gene product mutated in ataxia telangiectasia, is induced after DNA damage and is implicated in p53 modification and stabilization (2, 5). In the absence of ADR treatment, expression of either Snail or Slug results in significant repression of mRNA coding for the ATM kinase (Fig. 3d). Thus, the observed reduction in p53 protein levels after expression of Snail or Slug likely resulted from the combinatorial effects of three distinct mechanisms: a decline in p53 mRNA levels, increased MDM2-mediated turnover, and the loss of stabilizing modifications from the ATM kinase. The failure of Snail or Slug to alter the abundance of CHK2 and ARF suggests that the effects of aberrant expression of these transcriptional repressors on the p53 response are mediated through specific regulatory molecules. Since both CHK2 and ARF contain multiple E-box sequences (data not shown) and yet fail to respond to Snail or Slug, not all potential target loci respond to aberrant expression of these factors.
As levels of p53 protein were clearly affected by expression of Slug and Snail, we also analyzed transcript abundance of genes activated by p53 in response to genotoxic stress. Transcripts from a subset of these genes, including p53AIP1 (30), PIDD (25), PIG3 (35), and PUMA (40), were not detectable in MCF7 under any circumstances (data not shown). Others, including p53DINP1 (31), APAF-1 (41), and BAX (32), were unaffected by Snail (Fig. 3e and data not shown) or Slug (Fig. 3e). However, transcripts of the p53 targets BID (39), PIG8 (35), and Caspase 6 (27) were significantly repressed by ectopic expression of Snail or Slug (Fig. 3e). Thus, in addition to affects on p53 itself, aberrant Snail or Slug expression led to transcriptional effects on other genes integral to the DNA damage-induced programmed cell death pathway.
The repression at the CDH1, OCLN, TP53, BID, PIG8, and DFF40 loci could result from either direct effects or indirect effects of Snail and Slug. ChIP assays were performed to determine whether aberrantly expressed Snail and Slug bound to these loci. E-cadherin and occludin served as positive controls. After Snail or Slug expression, ChIP was performed, and coprecipitated DNA was analyzed by PCR. At all responsive loci, E-box sequences (Snail or Slug binding sites) were precipitated, whereas control sequences were not (Fig. 4). E-box DNA was amplified only after expression of the relevant repressor. Some loci containing E-boxes, such as APAF-1, are unresponsive, and the binding of Snail or Slug is not detected by ChIP. Thus, Snail and Slug can bind to the promoters of the TP53, BID, DFF40, OCLN, and CDH1 genes, the transcripts of which are all repressed after overexpression of Snail or Slug.
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Here, we provide an extension of these findings by demonstrating that aberrant expression of Snail or of Slug in breast adenocarcinoma cells protects against apoptosis induced by genotoxic stress. We found that ectopic expression of Snail in cells with an epithelial phenotype not only promotes phenotypic transition to a less differentiated, mesenchymal pattern but also provides protection against programmed cell death. However, the mechanistic details of the protective effect of Snail or Slug in breast carcinoma cells appear to differ dramatically from those observed in hematopoietic precursors that express Slug. Specifically, p53 abundance does not appear to be altered in hematopoietic progenitors isolated from Slug knockout mice (19, 33). In the present study, regulation of p53 at both RNA and protein levels was observed. The differences in the molecular details of protection from programmed cell death likely reflect major differences in the biology of hematopoietic progenitor cells versus mammary adenocarcinoma cell lines. These findings predict that Snail superfamily members may protect cells from programmed cell death through different mechanisms in different biological contexts.
Acquisition of invasive growth is a prerequisite to metastasis during cancer progression. Aberrant expression of Snail or of Slug in breast adenocarcinomas resulted in phenotypic alterations, including loss of cell adhesion and acquisition of invasive growth accompanied by enhanced cell survival (Fig. 7). Analysis of the proapoptotic transcriptional program regulated by these factors revealed interesting overlap with the DNA damage response pathway regulated by the tumor suppressor TP53. In fact, the p53 mRNA is itself a direct transcriptional target of Snail and Slug in this system. Factors implicated in p53 turnover also represent regulatory targets. Finally, aberrant Snail/Slug expression led to transcriptional repression of other proapoptotic genes that do not fall within classical p53-dependent pathways. Thus, Snail and Slug promote cell survival after genotoxic stress through direct transcriptional repression of genes involved in many aspects of programmed cell death. In the context of cancer progression, these findings predict that increased resistance to programmed cell death induced by common chemotherapeutic agents accompany the acquisition of invasive growth induced by aberrant expression of Snail or of Slug.
|
| ACKNOWLEDGMENTS |
|---|
This study was supported by a grant from NIDDK (DK065961 to P.A.W.). K.N.M. was supported by a grant from NIGMS (T32 GM08490). P.A.W. gratefully acknowledges financial support from the Wilbur and Hilda Glenn Family Foundation.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
2. Banin, S., L. Moyal, S. Shieh, Y. Taya, C. W. Anderson, L. Chessa, N. I. Smorodinsky, C. Prives, Y. Reiss, Y. Shiloh, and Y. Ziv. 1998. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281:1674-1677.
3. Batlle, E., E. Sancho, C. Franci, D. Dominguez, M. Monfar, J. Baulida, and A. Garcia De Herreros. 2000. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2:84-89.[CrossRef][Medline]
4. Bolos, V., H. Peinado, M. A. Perez-Moreno, M. F. Fraga, M. Esteller, and A. Cano. 2003. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J. Cell Sci. 116:499-511.
5. Canman, C. E., D. S. Lim, K. A. Cimprich, Y. Taya, K. Tamai, K. Sakaguchi, E. Appella, M. B. Kastan, and J. D. Siliciano. 1998. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281:1677-1679.
6. Cano, A., M. A. Perez-Moreno, I. Rodrigo, A. Locascio, M. J. Blanco, M. G. del Barrio, F. Portillo, and M. A. Nieto. 2000. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2:76-83.[CrossRef][Medline]
7. Carver, E. A., R. Jiang, Y. Lan, K. F. Oram, and T. Gridley. 2001. The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition. Mol. Cell. Biol. 21:8184-8188.
8. Dan, I., S. E. Ong, N. M. Watanabe, B. Blagoev, M. M. Nielsen, E. Kajikawa, T. Z. Kristiansen, M. Mann, and A. Pandey. 2002. Cloning of MASK, a novel member of the mammalian germinal center kinase III subfamily, with apoptosis-inducing properties. J. Biol. Chem. 277:5929-5939.
9. Fan, L. Z., and M. G. Cherian. 2002. Potential role of p53 on metallothionein induction in human epithelial breast cancer cells. Br. J. Cancer 87:1019-1026.[CrossRef][Medline]
10. Fernandez, Y., L. Espana, S. Manas, A. Fabra, and A. Sierra. 2000. Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance. Cell Death Differ. 7:350-359.[CrossRef][Medline]
11. Fujita, N., D. L. Jaye, M. Kajita, C. Geigerman, C. S. Moreno, and P. A. Wade. 2003. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 113:207-219.[CrossRef][Medline]
12. Grunert, S., M. Jechlinger, and H. Beug. 2003. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat. Rev. Mol. Cell. Biol. 4:657-665.
13. Hajra, K. M., D. Y. Chen, and E. R. Fearon. 2002. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res. 62:1613-1618.
14. Hajra, K. M., and E. R. Fearon. 2002. Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer. 34:255-268.[CrossRef][Medline]
15. He, T. C., S. Zhou, L. T. da Costa, J. Yu, K. W. Kinzler, and B. Vogelstein. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95:2509-2514.
16. Hemavathy, K., S. I. Ashraf, and Y. T. Ip. 2000. Snail/slug family of repressors: slowly going into the fast lane of development and cancer. Gene 257:1-12.[CrossRef][Medline]
17. Hirao, A., Y. Y. Kong, S. Matsuoka, A. Wakeham, J. Ruland, H. Yoshida, D. Liu, S. J. Elledge, and T. W. Mak. 2000. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287:1824-1827.
18. Ikenouchi, J., M. Matsuda, M. Furuse, and S. Tsukita. 2003. Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. J. Cell Sci. 116:1959-1967.
19. Inoue, A., M. G. Seidel, W. Wu, S. Kamizono, A. A. Ferrando, R. T. Bronson, H. Iwasaki, K. Akashi, A. Morimoto, J. K. Hitzler, T. I. Pestina, C. W. Jackson, R. Tanaka, M. J. Chong, P. J. McKinnon, T. Inukai, G. C. Grosveld, and A. T. Look. 2002. Slug, a highly conserved zinc finger transcriptional repressor, protects hematopoietic progenitor cells from radiation-induced apoptosis in vivo. Cancer Cell 2:279-288.[CrossRef][Medline]
20. Inukai, T., A. Inoue, H. Kurosawa, K. Goi, T. Shinjyo, K. Ozawa, M. Mao, T. Inaba, and A. T. Look. 1999. SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein. Mol. Cell 4:343-352.[CrossRef][Medline]
21. Ip, Y. T., and T. Gridley. 2002. Cell movements during gastrulation: snail-dependent and independent pathways. Curr. Opin. Genet. Dev. 12:423-429.[CrossRef][Medline]
22. Jallepalli, P. V., C. Lengauer, B. Vogelstein, and F. Bunz. 2003. The Chk2 tumor suppressor is not required for p53 responses in human cancer cells. J. Biol. Chem. 278:20475-20479.
23. Jiang, R., Y. Lan, C. R. Norton, J. P. Sundberg, and T. Gridley. 1998. The Slug gene is not essential for mesoderm or neural crest development in mice. Dev. Biol. 198:277-285.[Medline]
24. Kowalczyk, A. P., E. A. Bornslaeger, S. M. Norvell, H. L. Palka, and K. J. Green. 1999. Desmosomes: intercellular adhesive junctions specialized for attachment of intermediate filaments. Int. Rev. Cytol. 185:237-302.[Medline]
25. Lin, Y., W. Ma, and S. Benchimol. 2000. Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis. Nat. Genet. 26:122-127.[CrossRef][Medline]
26. Liu, X., H. Zou, C. Slaughter, and X. Wang. 1997. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89:175-184.[CrossRef][Medline]
27. MacLachlan, T. K., and W. S. El-Deiry. 2002. Apoptotic threshold is lowered by p53 transactivation of caspase-6. Proc. Natl. Acad. Sci. USA 99:9492-9497.
28. Metzstein, M. M., and H. R. Horvitz. 1999. The C. elegans cell death specification gene ces-1 encodes a snail family zinc finger protein. Mol. Cell 4:309-319.[CrossRef][Medline]
29. Nieto, M. A. 2002. The snail superfamily of zinc-finger transcription factors. Nat. Rev. Mol. Cell. Biol. 3:155-166.[CrossRef][Medline]
30. Oda, K., H. Arakawa, T. Tanaka, K. Matsuda, C. Tanikawa, T. Mori, H. Nishimori, K. Tamai, T. Tokino, Y. Nakamura, and Y. Taya. 2000. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 102:849-862.[CrossRef][Medline]
31. Okamura, S., H. Arakawa, T. Tanaka, H. Nakanishi, C. C. Ng, Y. Taya, M. Monden, and Y. Nakamura. 2001. p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. Mol. Cell 8:85-94.[CrossRef][Medline]
32. Oltvai, Z. N., C. L. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619.[CrossRef][Medline]
33. Perez-Losada, J., M. Sanchez-Martin, M. Perez-Caro, P. A. Perez-Mancera, and I. Sanchez-Garcia. 2003. The radioresistance biological function of the SCF/kit signaling pathway is mediated by the zinc-finger transcription factor Slug. Oncogene 22:4205-4211.[CrossRef][Medline]
34. Perez-Moreno, M., C. Jamora, and E. Fuchs. 2003. Sticky business: orchestrating cellular signals at adherens junctions. Cell 112:535-548.[CrossRef][Medline]
35. Polyak, K., Y. Xia, J. L. Zweier, K. W. Kinzler, and B. Vogelstein. 1997. A model for p53-induced apoptosis. Nature 389:300-305.[CrossRef][Medline]
36. Prives, C., and P. A. Hall. 1999. The p53 pathway. J. Pathol. 187:112-126.[CrossRef][Medline]
37. Ruohola, J. K., T. P. Viitanen, E. M. Valve, J. A. Seppanen, N. T. Loponen, J. J. Keskitalo, P. T. Lakkakorpi, and P. L. Harkonen. 2001. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells. Cancer Res. 61:4229-4237.
38. Tsukita, S., M. Furuse, and M. Itoh. 2001. Multifunctional strands in tight junctions. Nat. Rev. Mol. Cell. Biol. 2:285-293.[CrossRef][Medline]
39. Wang, K., X. M. Yin, D. T. Chao, C. L. Milliman, and S. J. Korsmeyer. 1996. BID: a novel BH3 domain-only death agonist. Genes Dev. 10:2859-2869.
40. Yu, J., L. Zhang, P. M. Hwang, K. W. Kinzler, and B. Vogelstein. 2001. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol. Cell 7:673-682.[CrossRef][Medline]
41. Zou, H., W. J. Henzel, X. Liu, A. Lutschg, and X. Wang. 1997. Apaf-1, a human protein homologous to Caenorhabditis elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405-413.[CrossRef][Medline]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|